ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,747Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 113

$470K Total Retail Price of All Prescriptions

Rank: 38 out of 113

452 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 452 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,296 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 439 344 1 1
HYDROCODONE-ACETAMINOPHEN 412 339 S3 2 7
LISINOPRIL 378 346 3 3
SIMVASTATIN 352 329 4 2
METOPROLOL TARTRATE 287 264 5 14
AMLODIPINE BESYLATE 244 226 6 4
OMEPRAZOLE 216 183 7 5
HYDROCHLOROTHIAZIDE 184 163 8 9
METFORMIN HCL 172 156 9 11
POTASSIUM CHLORIDE 171 150 10 12
CITALOPRAM HBR 169 162 11 17
FUROSEMIDE 153 124 12 6
WARFARIN SODIUM 139 124 13 8
METOPROLOL SUCCINATE 119 119 14 10
ALENDRONATE SODIUM 118 103 15 22
ZOLPIDEM TARTRATE 117 89 16 19
GABAPENTIN 113 76 17 18
ATORVASTATIN CALCIUM 111 83 18 15
FLUOXETINE HCL 105 77 19 31
LOSARTAN POTASSIUM 97 90 20 13
DOXAZOSIN MESYLATE 95 95 21 49
PANTOPRAZOLE SODIUM 91 77 22 52
ATENOLOL 87 84 23 16
FINASTERIDE 86 79 24 87
ALLOPURINOL 75 75 25 20
PREDNISONE 74 61 26 28
MORPHINE SULFATE ER 73 22 S2 27 79
CYMBALTA 72 47 28 37
CARVEDILOL 67 50 29 25
ADVAIR DISKUS 64 56 30 35
SPIRONOLACTONE 61 60 31 32
SYNTHROID 57 56 32 57
NYSTOP 57 49 32 188
DIOVAN 57 44 32 42
DONEPEZIL HCL 55 55 35 33
CLOPIDOGREL 55 55 35 56
OXYBUTYNIN CHLORIDE 52 41 37 89
LANTUS SOLOSTAR 51 36 38 59
SERTRALINE HCL 51 39 38 21
POLYETHYLENE GLYCOL 3350 51 38 38 77
VENLAFAXINE HCL ER 50 37 41 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.